Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Co. | 0.81% | 59.96 | 1.4% | $1550.16m | |
| JNJ | Johnson & Johnson | 0.56% | 140.34 | 0.7% | $880.30m | |
| PFE | Pfizer Inc. | 0.71% | 38.30 | 0.9% | $769.20m | |
| MRK | Merck & Co., Inc. | 0.10% | 88.84 | 0.7% | $670.35m | |
| ABBV | AbbVie, Inc. | 0.32% | 87.00 | 2.3% | $649.82m | |
| LLY | Eli Lilly & Co. | -0.14% | 119.60 | 1.1% | $340.88m | |
| AZN | AstraZeneca Plc | 0.13% | 47.68 | 1.2% | $136.29m | |
| RETA | Reata Pharmaceuticals, Inc. | -0.12% | 199.32 | 3.5% | $133.57m | |
| GSK | GlaxoSmithKline Plc | 0.66% | 45.51 | 0.2% | $128.61m | |
| NVS | Novartis AG | 0.34% | 91.95 | 0.2% | $128.17m | |
| KRTX | Karuna Therapeutics, Inc. | 3.35% | 67.63 | 0.0% | $101.66m | |
| NVO | Novo Nordisk A/S | -0.59% | 56.74 | 0.1% | $92.77m | |
| SNY | Sanofi | -0.11% | 46.03 | 0.2% | $69.98m | |
| ALLK | Allakos, Inc. | -4.63% | 117.36 | 0.0% | $64.39m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 2.05% | 54.86 | 0.0% | $38.47m |
Company Profile
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant, or MDR, bacterial infections. Its pipeline product candidates include SPR994, SPR741, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.